510(k) K972884
K972884 is an FDA 510(k) premarket notification submitted by Boston Biomedica, Inc. for the device "ACCURUN 146 CMV IGM POSITIVE CONTROL". The FDA issued a decision of Substantially Equivalent on Aug 22, 1997. The device falls under product code LKQ (Antibody Igm,If, Cytomegalovirus Virus), a Class II device regulated under 21 CFR 866.3175. Boston Biomedica, Inc. has 11 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Aug 22, 1997
- Date Received
- Aug 5, 1997
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Antibody Igm,If, Cytomegalovirus Virus
- Device Class
- Class II
- Regulation Number
- 866.3175
- Review Panel
- MI
- Submission Type
- 510(k)
Need the full FDA record for Boston Biomedica, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.